Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Canada's Newest Industry is Heading for a Supply Squeeze | ||
By: PR Newswire Association LLC. - 20 Sep 2017 | Back to overview list |
|
LONDON, September 20, 2017 /PRNewswire/ -- Netflix revolutionized the entertainment industry in 2007 with streaming, and now it's a $78-billion market cap company. Franco-Nevada, now worth $15 billion, and $9-billion Wheaton Precious Metals, changed the mining industry forever with royalty-streaming option for precious metals. For investors, it means diversified, reduced-risk exposure to some of the biggest markets in the industry, and now we can add the multi-billion-dollar cannabis market to this roster. Watching this week are Aphria Inc. (OTC: APHQF)(TSX: APH.TO), Cronos Group Inc (OTC: PRMCF) (TSX-V: MJN.V), Aurora Cannabis Inc (TSX: ACB.TO) (OTC: ACBFF), Zynerba Pharmaceuticals (NASDAQ: ZYNE), Scotts Miracle-Gro Co (NYSE: SMG) A little-known Canadian company is going for another first-streaming pot. And it's aiming to be of the dominant financier of the marijuana industry. It's a bold aim for Cannabis Wheaton (CBW.V; KWFLF), But in an expected $8-billion market in Canada alone, and in a country that could potentially dominate this industry because of first-mover advantage thanks to sweeping federal legislation, it's within visible reach. Canada's over 150,000 medical marijuana patients are already complaining about supply bottlenecks, and if Canada's growers are to meet projected demand for medicinal purposes only by 2021 when users grow to an expected 500,000, they will have to produce another 150,000 kilograms of pot, according to Canaccord Genuity. And that's just the medicinal market. When Canada's bill to legalize recreational use comes into force in less than a year, the country will really have a pot problem. Again, Canaccord Genuity estimates that by 2021 there will be an additional 3.8 million recreational users consuming 420,000 kilograms, or $6 billion of pot. Canada only has 40 licensed producers right now and last year, they grew only 31,000 kilograms-in other words, 5 percent of anticipated demand, according to the Financial Post. This is where Cannabis Wheaton makes its dramatic grand entrance. This is the world's first cannabis streaming company, and it's backed by a powerhouse team with industry trailblazer and political heavyweights from both conservative and liberal spectrums. Not only is Cannabis Wheaton jumping into a huge market where supply will struggle to reach demand, but it's offering a lifeline to new and existing growers who need financing to get off the ground fast. They need an innovative financing strategy, and Cannabis Wheaton is stepping in to fill the gap with a 'royalty' business model that is new to this market. And for investors, the major upside is that this model removes the risks associated with putting all your money into a single-crop producer. With Cannabis Wheaton, its business model is to 'stream' pot, and 15 partners have already been lined up, along with 1.4 million effective square feet of growing acreage. Here are 5 reasons to keep a close eye on Cannabis Wheaton (CBW.V; :KWFLF) #1 'Streaming' Deals Already Lined Up This pot financing pioneer is the major catalyst for change in Canada's expected $8 billion market-just for starters. The company's royalty business model reduces risk for everyone. For the investor, it means less risk associated with investment in a single-crop producer. For producers, it means more opportunities and avenues of financing to get growth off the ground. This is the evolution in finance of the traditional licensed cannabis producer-and Cannabis Wheaton is the only company on this track. And they've already sealed 15 partnership agreements in 17 facilities across six Canadian provinces to fund the construction and expansion of cannabis growing facilities and innovations. In return, they get minority equity interests and a portion of the pot produced. They've also got 39 solid clinic relationships, and this is growing fast, with access to over 30,000 registered medical marijuana patients. By 2019, just for starters, Cannabis Wheaton (CBW.V; KWFLF) will have more than 1.4 million effective square feet of pot cultivation. But it's not just about risk, for investors-it's about exposure. Through Cannabis Wheaton, exposure isn't limited to a single-crop: You get access to multiple licensed producers to take full advantage of this expected $8-billion industry. #2 Fast Track Scale-Up This company is all about scaling up quickly and capitalizing market share. And in this respect, it outshines its peers who are single-crop producers. The highlight of this quarter was Cannabis Wheaton's $15-million purchase of common shares of ABcann Global Corporation. This initial investment forms parts of a larger investment in ABcann that will net Cannabis Wheaton 50% of the grower's product on an additional 50,000 square feet of pot production, for 99 years. That deal closed in August, and it's just an initial investment, which forms part of a larger investment to fund a major expansion at ABcann's second production facility. ABcann production is set to come online in the fourth quarter of next year, and it should ramp up to full production in the first quarter of 2020. Using a $4.5/gram margin, that means an expected 70 percent IRR (internal rate of return) on what amounts to Cannabis Wheaton's approximate $41-million stream purchase, which infuses capital into ABcann in exchange for a stream of revenue from production in the future. When you combine the equity investment by Cannabis Wheaton, and potential liquidity, according to company guidance, that results in a blended expected IRR of 65 percent. This streaming/royalty deal is only the beginning. Cannabis Wheaton's model means maximizing profits by minimizing operational expenditures. Bottom line: What Netflix is to movies and TV series, Cannabis Wheaton is to pot. Or, it's what Silver Wheaton is the mining industry. Silver Wheaton strikes a deal with a miner to purchase part of its future metal production in exchange for upfront cash. Investors love it because it gives them lower-risk and diversified exposure to the mining industry. But this is even better because Cannabis Wheaton finances the facility and then takes a 'stream' of product that comes out of the facility, but it doesn't touch the product itself; it just takes the royalty. #3 Industry Trailblazers and Full-Spectrum Political Heavyweights The team behind Cannabis Wheaton (CBW.V; KWFLF) is pioneering, visionary and political savvy. That combination is everything in this sensitive industry. CEO Chuck Rifici has already led Canopy Growth Corp. to great success, taking it public in April 2014. Today's it's the darling of this space, with a $1-billion market cap. It's the benchmark for success among marijuana growers. This team is also backed by political heavyweights. That's because this is an industry that is already huge, and set to explode when recreational use is legalized. Rifici is former chief financial officer of the federal Liberal party, and Cannabis Wheaton's strategic advisor Rick Dykstra is a former Conservative Member of Parliament and current party president in Ontario. In June, the company added yet another heavy weight as president and director-industry-leading expert Hugo Alves. Alves founded and built his law firm's Cannabis Group-the leading cannabis-focused legal advisory business in the country-and this pioneer knows everything there is to know about cannabis licensing and regulations, with the right contacts at every industry vertical. That means that Cannabis Wheaton's streaming partners get the best of both worlds-financing and highly relevant expertise. #4 Canada's Pot Problem: Very Tight Supply The supply picture is so tight that Health Canada has had to streamline the approval process for growers because medical marijuana users have tripled in number since last year alone, according to Quartz. When it becomes legal recreationally, Deloitte estimates the economic impact of this industry will be worth $22.6 billion annually-in other words, more than that combined sales of beer, wine and spirits. From Canaccord Genuity's perspective, growers will have to come up with another 420,000 kilograms of pot to feed the anticipated 3.8 million recreational users hitting this market. But shortages are where things can get lucrative, and the Canadian government is also keen to make sure supply meets demand. That's why they moved to make the licensing process a lot easier in May last year. For Cannabis Wheaton (CBW.V; KWFLF), it's all about helping the streaming partners being the most dominant partners they can be, as Alves says. The gap Cannabis Wheaton is exploiting is a huge one: "There is a segment of the marketplace where people are trying to get their facilities built and they don't have access to capital at all," Alves told us. Finding money to build facilities when you have no assets is tricky. That's where the evolutionary genius of Cannabis Wheaton comes in, financing the producer at an aspirational valuation but letting the producer keep control, while Cannabis Wheaton takes an allocation of their production yield. #5 Mind the (Lucrative) Gap Cannabis Wheaton (CBW.V; KWFLF) is the first company to bring the streaming business model to this market, and its business model makes it easier for investors to get in on this burgeoning market with lower-risk exposure by financing diversified licensed producers. Pot producers are now under enormous pressure. Massive market share potential is being dangled in front of them in the most tantalizing manner-but without financing that still allows them to maintain control over their product, it's hard to get off the ground. And investors are wary because this is a risky business. Cannabis Wheaton is convinced it has discovered the answer that will take this burgeoning industry to the next logical step in its evolution. Producers get the best of both worlds, maintaining control over their companies but gaining access to financing and expertise on everything from regulations and licensing to cultivation. It's the full package, and a boost for investor confidence. Investors get broad exposure to one of the most exciting markets in the country-without the risk assigned to a bet on single-crop producers. And Cannabis Wheaton, well, it gets a nice, steady stream of pot royalties in an industry that is soon to be demanding much more product. This is the Cannabis Market 2.0, and Cannabis Wheaton(CBW.V; KWFLF) not only has first-mover advantage, but it has only-mover advantage, with the expertise and political weight to back it up. Once Canada is secured, this model will likely be looking to set it set up with first-mover advantage internationally. Other companies to watch closely: Aphria Inc. (OTCQB:APHQF) (TSX:APH.TO) is a Canada-based cannabis company which focuses on the production, sales, and distribution of legal marijuana. The company's business model focuses primarily on online sales, which is perfect for its patients. A simple point and click and the medication will arrive at the patient's in no time. Aphria's products are developed to treat to a variety of different patients and symptoms. The company offers several smoke free medications for those who are unable to consume the products in that manner. Aphria also produces low-THC products for patients who are more sensitive to marijuana's psychoactive properties. Aphria's large market appeal make the company an ideal choice for investors, as the company is sure to retain, as well as grow their customer base over time.
One of the primary objectives of Cronos Group is to destigmatize the medical use of marijuana and bring medicine to those who need it. Cronos Group has made it their priority to lead as an example for the industry, and provide the best care possible to the community. For investors, Cronos Group is especially appealing due to their core and strategic assets. Their portfolio is sure to impress, and will assuredly continue to grow in time. Aurora Cannabis Inc (OTCQX: ACBFF) (TSX: ACB.TO) which is a producer and distributer of medical marijuana across Canada. The company, formally Prescient Mining Corp, is a Vancouver-based business founded a little over one decade ago. Aurora's main objective is to bring medicine to the people reliably and economically, which sets it aside from many of its major competitors. In the marijuana industry, patients will often have to jump through hoops to procure their medication, but with Aurora's caring and knowledgeable staff, patients no longer have to worry. One of the most appealing things for patients ordering medications from Aurora is the company's delivery method. This marijuana major sells marijuana by phone and over the internet and then it is delivered straight to the patient's door. Aurora is a major player in Canada's cannabis scene. With a $1-billion market cap and solid growth, savvy investors are watching this stock like hawks.
Zynerba Pharmaceuticals is another company which has seen modest growth as the marijuana push gains speed. The company, which is at the forefront of new treatments focusing on THC, is set to make out like a bandit upon legalization. Not only will the act open more doors for the company, it will also bring well-deserved notoriety. Scotts Miracle-Gro Co (NYSE:SMG), a very well-known brand, is taking full advantage of the marijuana boom. This North American company's products include Miracle-Gro, Roundup, Liquafeed and other solutions for growers interested in keeping their plants healthy and bug-free. Because it is a household name, the company stands to benefit from the coming "green rush." Scotts is making large acquisitions within the hydroponic sector and its CEO has noted that the company's plans to take full advantage of the medical marijuana wave. In the past several months, Scotts Miracle-Gro has seen a notable gain in its stock price, likely attributed to the recent string of cannabis stories. Canada's upcoming legalization vote could very well spark further interest in the company, and send the stock further up in the food chain. By. Joao Piexe **IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY** DISCLAIMERS
DISCLAIMER: Safehaven.com is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with Safehaven.com or any company mentioned herein. The commentary, views and opinions expressed in this release by Safehaven.com are solely those of Safehaven.com and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. Contact Information: |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |